Dynatronics expands iontophoresis product line:
This article was originally published in Clinica
Dynatronics is adding a new iontophoresis product to its portfolio, having been appointed master distributor by the product's Tennessee-based developer Naimco. The IontoPlus iontophoresis electrodes are developed for administering certain medicinal drugs into the body through the skin using electricity, thereby eliminating the need for hypodermic needles. Salt Lake City, Utah-based Dynatronics is also distributor of Meditrodes, a line of iontophoresis electrodes developed by Houston, Texas company Life-Tech.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.